Rheumatology (Oxford, England)
Comment on: Risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study.
Hannah Khan
Published: 202510.1093/rheumatology/keaf665
No abstract available for this study.